A project-oriented immunotechnology platform

To speed up the generation and validation of new antibody candidates, MI-mAbs concentrates expertise and know-how on 4 key  technological  domains  and maximize exchanges between scientists and engineers.

MI-mAbs is structured around 3 main groups: antibodies, immuno-pharmacology and immuno-histochemistry/bioinformatics. The center carries out immuno-histochemistry studies with the support of the CRCM/IPC and CIML histology platforms.